Genticel

Developer of immunotherapies to treat infectious diseases and cervical cancer using CyaA vector technology

placeParis, Ile De France, France calendar_todayFounded 2001 groups32 employees language genticel.com

Innovation

8 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 833 times.

YearFilings
20122
20133
20145
20152
20166
20173
20183
20192
20201
20211
20221

Investor mix

9 investors on record; lead investors include Wellington Partners Venture Capital.

Investor typeCountShare
Venture capital222%
Private equity333%
Bank & private debt111%
Other / undisclosed333%
Coming soon